Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.
Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.
Growth Inhibitors
Role-tailored software systems for coordinating care at disaster sites: enhancing collaboration between the base hospitals with the field.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.
Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer. Oncotarget. 2015 Dec 22; 6(41):43743-58.
View in:
PubMed
subject areas
Antigens, CD
Antigens, Neoplasm
Cell Adhesion Molecules
Cell Line, Tumor
Disease Progression
Flow Cytometry
Fluorescent Antibody Technique
Glycosylation
Humans
Immunoblotting
Immunohistochemistry
Male
Mass Spectrometry
Neoplasm Proteins
Prostatic Neoplasms
Tissue Array Analysis
authors with profiles
Richard R. Drake